Somanetics Corporation To Present at UBS Global Life Sciences Conference and Maxim Group Growth Conference

TROY, Mich., Sept. 21 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) today announced that William Iacona, Somanetics chief financial officer, will present an overview of the Company at the following conferences:

• UBS Global Life Sciences Conference
  

Wednesday, September 23, 2009

10:00 a.m. ( ET)

Grand Hyatt, New York, NY

• Maxim Group Growth Conference
  

Tuesday, September 29, 2009

9:00 a.m. (ET)

Grand Hyatt, New York, NY

At these conferences, Mr. Iacona will provide insight about Somanetics' business strategy and its recent financial results. The presentations will be webcast live. The webcasts may be accessed by visiting the Presentations & Webcasts page in the Investor Relations section of Somanetics' website at www.somanetics.com. The presentations also will be archived on Somanetics' website for 30 days following the conferences.

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS((R)) Cerebral/Somatic Oximeter which noninvasively provides accurate, real-time blood oxygen measurements in patients greater than 2.5 kilograms, and trend monitoring of this parameter for individuals of any weight. The INVOS System is the only commercially-available cerebral/somatic oximeter proven to improve outcomes. Surgeons, anesthesiologists and other medical professionals can use data provided by the INVOS System, in conjunction with other available data, to identify oxygen imbalances in brain or other body tissue beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. The INVOS System is the clinical reference standard in cerebral/somatic oximetry, with an 11-year market track record, more than 700 clinical references and implementation at more than 700 U.S. hospitals. Somanetics also develops, manufactures and markets the Vital Sync(TM) System, a device that integrates data from bedside devices into a single system for enhanced patient assessment and decision making, data management and data storage. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit www.somanetics.com.

SOURCE Somanetics Corporation